Soluble FcεRI is increased in advanced mastocytosis and acts as a negative regulator of mast cell expansion and activation
sFcεRI is often elevated in patients with advanced SM and acts as negative regulator of growth and activation of neoplastic MCs.
Authors
- Gabriele Stefanzl (ORCID: https://orcid.org/0000-0002-6759-4662)
- Gregor Hoermann (ORCID: https://orcid.org/0000-0002-7374-4380)
- Georg Greiner (ORCID: https://orcid.org/0000-0002-0917-4117)
- Sonja Kopanja (ORCID: https://orcid.org/0000-0001-6737-3352)
- Daniel Ivanov (ORCID: https://orcid.org/0000-0003-1304-4224)
- Peter Valent
- Michel Arock
Institutions
- Sorbonne Université (FR)
- Comprehensive Cancer Center Vienna (AT)
- Assistance Publique – Hôpitaux de Paris (FR)
- Pitié-Salpêtrière Hospital (FR)
- Ludwig Boltzmann Institute Applied Diagnostics (AT)
- Ludwig Boltzmann Institute for Cancer Research (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.jaci.2026.02.008
- Primary Topic
- Mast cells and histamine
- Type
- article
- Field-Weighted Citation Impact
- 0.00